These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 15788882)

  • 1. [The efficacy of alpha-interferon in Korean patients with chronic hepatitis B].
    Koh KC
    Korean J Hepatol; 2005 Mar; 11(1):31-3. PubMed ID: 15788882
    [No Abstract]   [Full Text] [Related]  

  • 2. [Problems and strategies during interferon therapy for hepatitis B].
    Zhao LS
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):378-9. PubMed ID: 16732917
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of chronic hepatitis B.
    Moreno Otero R
    Rev Esp Enferm Dig; 2000 Sep; 92(9):555-60. PubMed ID: 11138237
    [No Abstract]   [Full Text] [Related]  

  • 4. [A clinical study of consensus interferon alpha treatment in chronic hepatitis B virus-infected patients].
    Yan T; Wang HF; Li K; Zhang AM
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):314-5. PubMed ID: 17456329
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chronic hepatitis. New therapeutic approaches on trial].
    Kaiser S
    MMW Fortschr Med; 2000 Oct; 142(43):61. PubMed ID: 11098616
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Desai HG
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929870
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Babu S
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929872
    [No Abstract]   [Full Text] [Related]  

  • 8. [The efficacy of lamivudine in Korean patients with chronic hepatitis B].
    Choi JY
    Korean J Hepatol; 2005 Mar; 11(1):25-30. PubMed ID: 15788881
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolving approaches to the treatment of chronic hepatitis B virus infection in children.
    Kerkar N; Shneider BL
    J Clin Gastroenterol; 2005 Jan; 39(1):7-9. PubMed ID: 15599202
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of chronic hepatitis B with human lymphoblastoid interferon: results of a controlled trial.
    Mazzella G; Villanova N; Amed MA; Barbara L; Saracco G; Rizzetto M; Cancellieri C; Roda E
    J Chemother; 1989 Jul; 1(4 Suppl):1094-5. PubMed ID: 16312786
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of treatment of chronic hepatitis B with interferon-alpha.
    Nagral A
    Natl Med J India; 2003; 16(3):175; author reply 175-6. PubMed ID: 12929871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic effect of alpha 1b interferon on patients with chronic hepatitis B: changes in serological fibrosis markers and histology].
    Zhang HY; Lu H; Li XM; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Feb; 11(2):117-8. PubMed ID: 12648417
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term prognosis of interferon nonresponder children with hepatitis B.
    Koçak N; Gürakan F; Saltik IN; Ozen H; Yüce A
    Am J Gastroenterol; 2000 Jul; 95(7):1841. PubMed ID: 10926001
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of chronic hepatitis B with a combination of acyclovir and alpha-lymphoblastoid interferon.
    Schalm SW
    J Chemother; 1989 Jul; 1(4 Suppl):1112-4. PubMed ID: 16312795
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship between HBV genotypes and anti-viral therapeutic efficacy of interferon-alpha.
    Ma JC; Wang LW; Li XJ; Liao YF; Hu XY; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2007 Apr; 6(2):166-71. PubMed ID: 17374576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some strategies for the long-term treatment of chronic hepatitis B].
    Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):537-8. PubMed ID: 16042895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Future perspectives and strategies in managing resistance to analogue antiviral drugs in the treatment of chronic hepatitis B].
    Bourlière M
    Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S34-6. PubMed ID: 17075495
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha therapy in HBeAg-negative chronic hepatitis B: a long-term prospective study from north-western Greece.
    Baltayiannis G; Katsanos K; Karayiannis P; Tsianos EV
    Aliment Pharmacol Ther; 2006 Aug; 24(3):525-33. PubMed ID: 16886919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.